Exceptional pathologic complete response achieved with androgen deprivation and docetaxel therapy in Gleason 10 prostate cancer

Pathologic complete response is an exceptionally rare occurrence in prostate cancer, especially in the setting of poorly differentiated cancer, with high risk and poor prognostic features. Patient reviewed and signed an informed consent. The case details were collected. Patient had PSA of 52.6 ng/dl...

Descripción completa

Detalles Bibliográficos
Autores principales: Vaishampayan, Ulka, Shi, Dongping, Abdulfatah, Eman, Aoun, Hussein, Wynberg, Jason
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6357690/
https://www.ncbi.nlm.nih.gov/pubmed/30740311
http://dx.doi.org/10.1016/j.eucr.2019.01.018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6357690/
https://www.ncbi.nlm.nih.gov/pubmed/30740311
http://dx.doi.org/10.1016/j.eucr.2019.01.018

Ejemplares similares